glp-1 vs sglt2 diabetes Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study Assessing the proportion of patients
Description
Getting to the guts of the matter
Rosenkilde, MM (July 2021) 'The role of incretins on insulin function and glucose homeostasis', Endocrinology , 162/7, bqab065
High-Quality Weight Loss & Muscle Preservation The conversation is shifting from simply reducing body weight to achieving high-quality weight loss, preserving lean muscle mass while reducing fat
However, the short half-life of GLP-1 greatly precludes its clinical utilization
At the same time almost 40% of adults and a quarter of children with Medicaid have obesity and may benefit from having access to the drugs, according to KFF
